Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?
Joanna Dulińska-Litewka(Jagiellonian University), Krzysztof Okoń(Jagiellonian University)
Cited by 9
Related Papers
Superparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications
|Materials|2019|562
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
|Aging|2017|286
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
|Oncotarget|2014|246
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
|Oncotarget|2016|110
Advances in Targeting Signal Transduction Pathways
|Oncotarget|2012|46